Please provide your email address to receive an email when new articles are posted on . The FDA designated Abiomed’s recall of its instructions for use for its left-sided blood pumps as class I, the ...

Abiomed updated warnings on more than 60,000 Impella Left Sided Heart Pumps because the device might cut the wall of the heart’s left ventricle, the FDA said March 21. After 129 serious injuries, ...

Abiomed is recalling all Impella left-sided blood pumps in the US over a potential safety issue when used in patients with a transcatheter aortic valve replacement (TAVR) stent ― something that is not ...

Abiomed is recalling the instructions for use (IFU) for its Impella left-sided blood pumps because the pump catheter may perforate the wall of the left ventricle. According to the recall notice, "use ...

Loop is a DIY automated insulin delivery system with more customization and features than FDA-approved systems on the market. Justin Eastzer is a CNET Perspectives Contributor and former CNET host.

Please provide your email address to receive an email when new articles are posted on . In a cohort of patients who underwent high-risk PCI, mechanical circulatory support with a microaxial blood pump ...

The FDA has issued an alert about a potentially high-risk issue involving Abiomed’s Automated Impella Controller, which is used with the company’s blood pump systems. Abiomed, now part of Johnson & ...

On Thursday, Johnson & Johnson’s (NYSE:JNJ) Abiomed said it is recalling its Impella Left Sided Blood Pumps because the pump catheter may perforate (cut) the wall of the left ventricle in the heart.

Severe pediatric cardiac decompensation has a mortality risk of 50-65% and is the leading cause of death in children. Heart transplantation is the current standard of care for end-stage pediatric ...

(RTTNews) - CytoSorbents Corp. (CTSO), a company focused on blood purification technology, on Thursday announced the launch and immediate availability of its PuriFi hemoperfusion machine in the ...